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ABSTRACT  
Background – Compromised structural integrity of the endothelium and higher microvessel 
density increase vascular permeability. We investigated whether vascular permeability 
measured in vivo by magnetic resonance imaging (MRI) using the albumin-binding contrast 
agent, gadofosveset, is a surrogate marker of rupture-prone atherosclerotic plaque in a rabbit 
model. 
Methods and Results –  New Zealand White rabbits (n=10) were rendered atherosclerotic by 
cholesterol-diet and endothelial denudation.  Plaque rupture was triggered with Russell's viper 
venom and histamine. Animals were imaged before (pre) triggering, at 3 and 12-weeks, to 
quantify plaque area, vascular permeability, vasodilation, and stiffness and post-triggering to 
identify thrombus. Plaques identified on the pre-trigger scans were classified as stable or 
rupture-prone based on the absence or presence of thrombus on the corresponding post-trigger 
MRI, respectively. All rabbits developed atherosclerosis and 60% had ruptured plaques. 
Rupture-prone plaques had higher vessel wall relaxation rate (R1) (2.30±0.5s-1 vs. 1.86±0.3s-1, 
P<0.001), measured 30min following gadofosveset administration, and higher R1/plaque area 
ratio (0.70±0.06 vs. 0.47±0.02, P=0.01) compared with stable plaque at 12-weeks. Rupture-
prone plaques had higher percent change in R1 between the 3 and 12-weeks compared to 
stable plaque (50.80±7.2% vs. 14.22±2.2%, P<0.001). Immunohistochemistry revealed 
increased vessel wall albumin and microvessel density in diseased aortas and especially in 
ruptured plaque. Electron microscopy showed lack of structural integrity in both luminal and 
microvascular endothelium in diseased vessels. Functionally, the intrinsic vasodilation of the 
vessel wall decreased at 12-weeks compared to 3-weeks (18.60±1.0% vs. 23.43±0.8%, 
P<0.001) and in rupture-prone compared to stable lesions (16.40±2.0% vs. 21.63±1.2%, 
P<0.001). Arterial stiffness increased at 12-weeks compared to 3-weeks (5.00±0.1m/s vs. 
2.53±0.2m/s, P<0.001) both in animals with stable and rupture-prone lesions.   
	 3	
Conclusions – T1 mapping using an albumin-binding contrast agent (gadofosveset) could 
quantify the changes in vascular permeability associated with atherosclerosis progression and 
rupture-prone plaques.  
 
INTRODUCTION 
Despite the successful implementation of several primary and secondary prevention strategies, 
atherosclerosis remains a crucial etiologic factor underlying stroke and myocardial infarction, 
which are the major causes of mortality and morbidity in Europe and the United States 1, 2. 
Rupture of unstable atherosclerotic lesions is a major factor in the development of the 
thromboembolic sequelae following atherosclerosis and symptomatic disease 3, 4. Damaged 
vascular endothelium and increased microvessel density leads to leakage of plasma 
components, including albumin, fibrinogen, erythrocytes, lipids, and inflammatory cells into the 
vessel wall and accelerate disease progression and lesion instability 4-7. 
Vascular endothelium controls both vascular permeability, by regulating the flux of blood 
components through the vessel wall via intracellular and intercellular pathways 8, and vascular 
tone by balancing the production of vasodilators (e.g., nitric oxide, prostacyclin) and 
vasoconstrictors (e.g., endothelin-1, angiotensin II). However, cardiovascular risk factors impair 
both the structural integrity and functionality of endothelial cells, which renders the vessel wall 
pro-atherogenic by increasing endothelial permeability and attenuating endothelium-depended 
vasodilation 9, 10. Additionally, plaque growth, local hypoxic conditions and inflammation stimulate 
microvessel growth within the plaque 4, 11. Microvessel density correlates with the extent of the 
necrotic core, intraplaque haemorrhage 4, 12, and inflammatory infiltrates 13, 14 and is higher in 
ruptured compared with stable lesions in both the coronary 4, 15 and carotid arteries 4, 13-18. 
Structurally, intraplaque and adventitial microvessels are immature, dysmorphic and fragile. 
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They lack surrounding α-actin-positive mural cells and are covered by structurally 
compromised endothelial cells, which makes them more leaky and permeable 11, 13, 14, 18-20. 
Dynamic contrast enhanced (DCE) MRI using non-specific contrast agents e.g., Gd-
DTPA has extensively been used to study plaque angiogenesis. Measurements of the contrast 
agent kinetic parameters, such as the transfer constant (Ktrans) or the area under the signal 
intensity curve (AUC) showed correlation of contrast uptake with microvasculare density 21-24, 
adventitial vasa-vasorum 25, 26 and with sites of active inflammation 27 in both animal models and 
man. We 28-30 and others 22-24, 31	have used the albumin-binding MRI contrast agent, 
gadofosveset, to image vascular remodeling and treatment response in experimental and 
human atherosclerosis. Collectively, these studies show that gadofosveset uptake occurs 
through damaged endothelium and/or microvessels and may be a surrogate marker of vascular 
permeability. Gadofosveset is a clinically approved gadolinium-based agent. Approximately 70% 
of injected gadofosveset binds reversibly to plasma albumin that increases its r1 relaxivity by 5-
10 fold (r1= 25 mM-1s-1) compared to the free fraction (r1= 5 mM-1s-1) 32.  
In this study, we used the MR albumin-binding contrast agent, gadofosvest, and T1 
mapping in a rabbit model of atherosclerosis and controlled plaque rupture to investigated 
whether increased vascular permeability associates with plaque progression and rupture-prone 
plaque. This kind of non-invasive assessment of vascular leakage could provide both diagnostic 




Ten New Zealand White (NZW) rabbits (Harlan, UK, 3 months old, male, 2.5 kg) were fed 
a 1% cholesterol-diet (Special Diet, Services, UK) for 2-weeks prior to and 6-weeks after aortic 
denudation. This was followed by 4-weeks of normal chow diet (Figure 1; Supplemental Data) 
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33. Aortic denudation was performed under general anesthesia with acepromazine (0.75 mg/kg 
IM), ketamine (35 mg/kg, IM), xylazine (5 mg/kg IM) and maintained with isofluorane 1-2%. A 3F 
Fogarty catheter was introduced in the aorta through a right femoral artery cutdown. The 
catheter was first advanced to the level of the diaphragm, inflated with saline and was retracted 
to the femoral artery. This procedure was repeated 3 times. Subsequently, the catheter was 
removed, and the incision closed.  
At the end of the 12-weeks, diseased rabbits were injected with Russell’s-viper-venom 
(0.15 mg/kg IP; Enzyme Research Laboratories, Swansea, UK), a procoagulant factor, followed 
30min later by histamine, a vasoconstrictor in rabbits (0.02 mg/kg IV; Sigma-Aldrich, MO) to 
induce plaque rupture and thrombosis. This procedure was repeated twice within 4h. Four, non-
balloon injured, age and gender matched rabbits (3 months old; male) were fed a normal diet for 
12-weeks and used as controls. All procedures were approved by the United Kingdom Animal 
(Scientific Procedures) Act 1986. 
 
In vivo MR Imaging  
The abdominal aorta of NZW rabbits was imaged using a 3T Philips Achieva MR scanner 
(Philips Healthcare, Best, The Netherlands) and a 32-channel cardiac coil. Animals were imaged 
at 3 time points; 3-weeks and 12-weeks after initiation of the experimental protocol (pre-trigger 
scans) and 24h after the pharmacological triggering (post-trigger scan) (Figure 1; 
Supplemental Data).	 
The pre-trigger MRI included acquisition of native scout, phase-contrast MR angiography 
(PCA) and T1-weighted black-blood (T1wBB) images. The PCA images were acquired for 
visualization of the aorta, the renal branches, and the iliac bifurcation with: repetition time (TR) 
=20ms, echo time (TE)=3ms, flip angle (FA)=15°, FOV=300x150mm, acquired matrix=256x122, 
resolution=1.2x0.6x1mm, slices=20, Venc=150cm/s and averages=2. The maximum intensity 
projection (MIP) images were used to plan the subsequent scans. ECG-triggered 2D T1wBB 
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images were acquired with: TR/TE=2 heartbeats/5.4ms, profile order=centric, echo train 
length=6, BB delay=350ms, FOV=120x85mm, acquired matrix=384x270, 
resolution=0.31x0.31mm, slice thickness=4mm, slices=25 and averages=2. Subsequently, 
gadofosveset (0.03mmol/ kg, Ablavar, Lantheus Medical Imaging, North Billerica) was 
administered intravenously (IV). Immediately and up to 30 minutes after contrast injection, 
steady state free procession (SSFP) cine and quantitative phase contrast angiography (QFlow) 
images were acquired to measure functional parameters of the vessel wall. 2D retrospectively 
EGC triggered SSFP images were acquired with TR/TE=7.8/3.9ms, FA =60°, FOV=85x121mm, 
acquired matrix=172x241, resolution=0.5x0.5mm, slice thickness=5mm, slices=11, heart 
phases=18, averages=3. 3D ECG triggered fast gradient echo QFlow images were acquired 
with: TR/TE=17/10ms, FA =20°, FOV=85x121mm, acquired matrix=172x241, 
resolution=0.5x0.5mm, slice thickness=8mm, slices=1, heart phases=12, averages=2, 
Vencoding=150cm/s in the FH direction. 
 T1 mapping images were acquired 30min following gadofosveset administration using a 
Look-Locker based gradient-echo sequence that employs a non-selective inversion pulse with 
inversion times ranging from 20-2000ms, followed by eight segmented readouts for eight 
individual images for each of the two Look-Locker trains. In total, sixteen images per slice were 
acquired. T1 mapping parameters were: TR/TE=5.2/2.7ms, FA =10°, FOV=80x58mm, acquired 
matrix=200x141, resolution=0.4x0.4mm, slice thickness=4mm, slices=10, averages=1. Two 
stacks of T1 mapping sequences were acquired to cover a total length of 80mm in the FH 
direction.   
Finally, the post-triggering MRI session was performed 24h after the pre-trigger scan and 
included acquisition of scout, PCA and native T1wBB images to visualize thrombus. Only the 
diseased rabbits underwent post-triggering MRI.  
After the final MRI session, rabbits received heparin (1000 USP units IV, Sigma-Aldrich) 
to prevent post-mortem blood clotting and were sacrificed with a bolus injection of sodium 
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pentobarbital (100 mg/kg IV). The aortas were marked with suture ligature at distances above 
and below the left renal branch to match the total length imaged in vivo. The total length was 
measured with a ruler and the vessel was marked on its anterior site at every 2cm with tissue 
dye. After extraction, the ligatures were used to re-extend the aortas to their physiological 
length, with the ink marks used to stretch the vessel equally. Subsequently, the aorta of each 
animal was divided in segments that were allocated for different ex vivo studies. A total of 36 
diseased vascular segments containing 21 stable and 15 ruptured plaque and 4 control 
segments were analyzed. Aortic segments allocated for light microscopy (n=18; 2 control; 10 
stable and 6 ruptured plaques) and ICP studies [n=14; 2 control, 6 stable, 6 ruptured)] were 
snap frozen and stored in -80oC Aortic segments used for electron microscopy [TEM n=8 (2 
control, 3 stable and 3 ruptured), X-ray (n=2)] studies were fixed in 2% gluteraldehyde in 0.1 
mol/L sodium phosphate buffer as described below. 
 
MR Image analysis 
Pre-trigger images acquired at 3 and 12-weeks were used to quantify plaque area, vascular 
permeability, aortic vasodilation and stiffness. The vessel wall was manually segmented by 
tracing the adventitial and the lumen contours on T1wBB images using the software OsiriX 
(OsiriX Foundation, Geneva, Switzerland). Plaque area (PA) was calculated as:  
 
Changes in plaque area between the 3 and 12-weeks were calculated using the T1wBB images 
based on the following formula:  
 
 
T1 mapping images were used to calculate the vessel wall relaxation rate (R1) on a pixel-by-
pixel basis using a 3-parameter curve fitting procedure of the longitudinal magnetization 
including a T1 correction with an in house software (Matlab, Natick, MA) 30min after 
%ΔT1wPA = T1wPA12weeks −T1wPA3weeks( )T1wPA3weeks
*100
Plaque Area(PA) =Vessel Area− LumenArea
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administration of gadofosveset as previously published 34 and further explained in the 
Supplemental Data.  
Changes in vascular permeability between the 3 and 12-weeks were calculated based on the 
following formula:  
 
Retrospectively ECG triggered SSFP images were used to calculate the intrinsic vasodilation of 
the vessel wall. The end-diastolic (ED) and end-systolic (ES) areas were manually segmented 
and the vasodilation of the aorta was calculated based on the formula: 
     
 
Changes in aortic vasodilation between the 3 and 12-weeks were calculated based on the 
following formula:  
 
 
Pulse-wave velocity (PWV) was used to characterize arterial stiffness. Qflow images were 
analysed using ViewForum (Philips Healthcare, Best, The Netherlands) and PWV was 
calculated based on the formula 35. 	
 
where Δt=the time to peak velocity, Δx=distance between the proximal (immediately inferior to 
the left renal branch) and distal (immediately superior to the iliac bifurcation) slices of the 
imaging volume.  




R1 12weeks− R1 3weeks( )
R1 3weeks
*100
%Vasodilation = ED−ES( )ED *100
%ΔVasodilation = Vasodilation 12weeks−Vasodilation 3weeks( )Vasodilation 3weeks
*100
%ΔPWV = PWV 12weeks−PWV 3weeks( )PWV 3weeks
*100
PWV (m / s) = Δx( )
Δt( )
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Post-trigger images were used to identify the presence or absence of mural thrombus and to 
retrospectively classify the corresponding lesions, identified on the 12 weeks pre-trigger scan, in 
stable and rupture-prone, respectively 33, 36, 37. 
 
Histology 
Aortic segments (n=18; 2 control, 10 stable and 6 ruptured plaques) were transversely 
cryosections (10 µm) and stained with Masson’s trichrome (Sigma Aldrich) to identify cellular 
components and thrombus. Ruptured plaques were defined as those with attached platelet and 
fibrin-rich thrombus whereas plaques without thrombus were defined as stable 33, 36.  The 
distances from the renal branches and the iliac bifurcation were used as internal anatomical 
markers to match the MR images and histological sections. Immunohistochemistry was carried 
out using biotinylated primary anti-human sheep polyclonal antibody for albumin (1:50, Abcam # 
ab8940, Cambridge, MA), and mouse monoclonal antibody for CD31 (1:50, DAKO JC70A, 
Cambridgeshire, UK) to locate the endothelium. Primary antibody binding was located using an 
avidin-peroxidase complex (Vector Laboratories, Burlingame, CA). Immunopositive areas were 
analyzed on digital images by computerized planimetry using ImageJ (National Institutes of 
Health). The immunopositive area (albumin) was segmented on the images and expressed as a 
percentage of the total plaque area. Plaque microvessels (immunopositive area for CD31) were 
counted individually and microvessel density was calculated by measuring the total number of 
microvessels and dividing by total plaque area.  
 
Transmission Electron Microscopy (TEM) 
The structural integrity of luminal and microvascular endothelium was studied with TEM. Aortic 
segments (n=8; 2 control, 3 stable and 3 ruptured) were fixed in 2% gluteraldehyde in 0.1 mol/L 
sodium phosphate buffer (pH 7.4) for 2h, washed with sodium phosphate buffer for 2h, and post-
fixed in 1% OsO4 for 2h. Samples were dehydrated through a graded series of ethanol and 
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embedded in epoxy resin. Semi-thin sections (0.2 µm) were stained with toluidine blue for light 
microscopy examinations and were used to guide sampling for transmission electron microscopy 
studies. Thin sections (0.09 µm) were collected on 150-mesh copper grids and double stained 
with uranyl acetate and lead citrate for electron microscopy examinations (H7650, Hitachi, 
Tokyo, Japan).  
 
Electron Probe X-Ray Microanalysis 
Aortic segments (n=2; stable plaque) were prepared by cryofixation under liquid nitrogen. 
Cryosections were cut at -120°C, transferred to Pioloform-coated nickel grids, and freeze-dried 
overnight. The sections were coated with a thin layer of carbon and viewed and analyzed in an 
FEI Tecnai 12 electron microscope equipped with an EDAX energy-dispersive x-ray 
spectroscopy detector. Mapping was achieved with EDAX software (EDAX) and used to display 
the distribution of gadolinium within the vessel wall. 
 
Inductively coupled mass spectrometry (ICP–MS) for gadolinium quantification  
To ensure the same pharmacokinetics/biodistribution of gadofosveset measured by T1 mapping 
in vivo and ICP-MS ex vivo the animals allocated for ICP-MS measurements were injected with 
gadofosveset after the post-trigger MRI and the agent was allowed to circulate in the body for 
30min. The animals were then euthanized and aortas were collected as described above. For 
ICP-MS measurements aortic segments (n=14; 2 control, 6 stable, 6 ruptured) were digested in 
70% nitric acid at 56oC for 15-18h and diluted with deionized water for ICP-MS analysis. A 







The Statistical Package for the Social Sciences 21.0 (IBM Corporation, Somers, NY, USA) was 
used. For 2-group comparisons, continuous variables (e.g., control vs. diseased, control vs. 
stable/vulnerable, stable vs. vulnerable at the same time point) were compared using an 
unpaired t-test. However, a paired t- test was used to compare repeated measurements 
between 3- and 12-weeks (e.g., R1 at 3 and 12 weeks for the same animal). Correlation analysis 
was performed using the Spearman test. Multiple segments from the same animal are assumed 
to be independent of each other. A second observer blinded to plaque status (stable/rupture-
prone) re-analysed the R1 maps to test the reproducibility of this measurement. The 
intraobserver and interobserver variability was assessed by using the interclass correlation 
coefficient (ICC) for continuous variables (R1 values). The ability of MRI variables to detect 
rupture-prone plaque was assessed using sensitivity, specificity, positive and negative predictive 
values (PPV and NPV), and receiver-operator characteristic curve (ROC) and its area under the 
curve (AUC). Logistic regression analysis was used to identify predictors of rupture-prone plaque 
with the presence/absence of thrombus as the outcome variable. Continuous data are presented 
as the mean±SEM. Probability values of P<0.05 were considered significant. 
 
RESULTS 
Vascular Permeability is Higher in Rupture-Prone compared to Stable Plaque   
Consistent with previous studies, the 12-week pre-trigger MRI showed aortic atherosclerosis in 
all animals and the post-trigger MRI showed plaque rupture in 6/10 (60%) of the animals 
characterized by mural thrombus 33, 36, 37. In a representative example, pre-trigger T1wBB 
images showed increased vessel wall area between 3 (Figure 1A &1C) and 12 weeks (Figure 
1E &1G) (3.75±0.12 vs. 4.20± 0.18mm2, P=0.04) indicating atherosclerosis progression. 
However, the plaque area was similar between stable and rupture-prone plaque at both the 3-
weeks (3.82±0.13 vs. 3.71± 0.23mm2, P=0.7) and 12-weeks (4.00±0.2 vs. 4.33±0.35mm2, 
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P=0.58). The vessel wall R1 relaxation rate, measured 30min after gadofosveset administration, 
was similar between stable and rupture-prone plaques at 3-weeks (Figure 1B & 1D) (1.50±0.12 
s-1 vs 1.70±0.2s-1). Conversely, at 12-weeks, the rupture-prone plaque had significantly higher 
R1 relaxation rate compared to the stable plaque, indicating higher vascular permeability 
(1.83±0.25 s-1 vs 2.54±0.3s-1) (Figure 1F & 1H). Post-trigger T1wBB images (Figure 1I & 1K) 
and corresponding histology (Figure 1J & 1L) show absence of thrombus in the case of the 
stable plaque and presence of thrombus overlying the ruptured plaque. An additional example 
demonstrating R1 and T1 maps, both in gray-scale (B, G, D & I) and color-coded formats (C, H, 
E, & J), in visualizing and segmenting the vessel wall to calculate the vessel wall T1/R1 values is 
illustrated in (Figure 2; Supplemental Data). Interclass correlation coefficient (ICC) analysis 
revealed high intra-rater agreement (ICC, 0.89; 95% confidence interval [CI], 0.83-0.93, 
P<0.001) and good inter-rater variability (ICC=0.75, 95% CI=0.4-0.79, P<0.001) for the 
measurement of vessel wall relaxation rate R1. The results of the blinded observer are illustrated 
in Supplemental Table 1, along side observer one. 
 
Quantitative MRI Measurements 
Quantification of vascular permeability to gadofosveset (R1) during atherosclerosis 
progression in the rabbit aorta is illustrated in Figure 2.  The vessel wall R1 was similar in control 
and diseased animals at 3-weeks (1.69±0.02s-1 vs. 1.71±0.2s-1, P=0.19) but was significantly 
higher at 12-weeks (1.71±0.2s-1 vs. 2.00±0.1s-1, P<0.001) (Figure 2A). When the vascular 
segments were classified in stable and rupture-prone, the vessel wall R1 was similar between the 
groups at 3-weeks (1.70±0.17s-1 vs. 1.75±0.6s-1, P=0.33). However, at 12-weeks, rupture-prone 
plaques had significantly higher gadofosveset uptake resulting in higher R1 values compared to 
stable plaque (2.30±0.5s1 vs.1.86±0.3s-1, P<0.001). Paired t- test analysis showed a significant 
increase of R1 between 3- and 12-weeks for both the stable (1.70±0.17 vs. 1.86±0.3, P<0.001) 
and rupture-prone lesions (1.75±0.6 vs. 2.30±0.5, P<0.001) (Figure 2B). To account for 
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changes in R1 that might be affected merely by lesion size the R1 was normalized to plaque 
area, as measured by T1wBB images. The R1/ plaque area ratio was higher in rupture-prone 
compared to stable plaque (0.70±0.06 vs. 0.47±0.02, P=0.01) at 12 weeks (Figure 2C). Paired t- 
test analysis showed a small but significant increase in the R1/ plaque area ratio between 3- and 
12-weeks for rupture-prone lesions (0.55±0.04 vs. 0.70±0.06, P=0.04). The percentage increase 
in R1 between 3 and 12-weeks was higher for rupture-prone compared to stable plaque 
(50.80±7.2% vs. 14.22±2.2%, P<0.001) (Figure 2D). Gadolinium concentration was higher in 
diseased compared to control animals (50.45±9.2 vs. 22.13±1.0 µg/gr tissue, P=0.03) and 
rupture-prone compared to stable plaque (80.54±6.13 vs. ± 32.40±4.0 µg/gr tissue, P<0.001) as 
calculated by ICP-MS.  
 
Vascular Permeability to Albumin is a Predictor of Plaque Rupture 
The value of the quantitative assessment of vascular permeability (R1) after administration of 
gadofosveset in detecting rupture-prone plaque was analyzed with ROC curves at 12-weeks 
(Figure 3A-3C). ROC curves showed that R1, R1 / plaque area and the %ΔR1 between 3 and 
12-weeks had high areas under the curve and were good predictors of rupture-prone (Table 1). 
Logistic regression analysis showed that the R1 at 12wks is a predictor of rupture-prone plaque 
(P<0.001, OR=11.45, CI = 3.89-33.72).  
 
Histological analysis shows higher Intra-Vessel Wall Albumin and Microvessel Density in 
Ruptured compared to Stable Plaque 
Quantification of the albumin-immunopositive areas showed a significant increase in intra-vessel 
wall albumin in diseased compared to control vessels (Figure 4A-4C; brown color and 4D) 
(33.00±3.3% vs. 12.91±0.8%, P=0.01) and particularly in ruptured compared to stable plaque 
(44.84±4.0%vs. 25.93±3.0%, P=0.03) (Figure 4E). CD31-staining of the endothelium (Figure 
4F-4H; brown color) showed intact, continuous endothelial cells in control vessel, less structured 
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cells in stable plaque, and fragmented cells covering the lumen of ruptured plaque. Endothelium 
staining also showed higher microvessel density in ruptured compared to stable plaque 
(21.00±2.24 vs 7.32±0.96, P<0.001) and absence of microvessels in control arteries (Figure 4I-
4K; asterisks and 4L).  
 
Transmission Electron Microscopy (TEM) shows abnormal morphology and aberrant 
junctions of luminal and microvascular endothelial cells  
TEM was used to examine the ultrastructural integrity of luminal and microvascular endothelial 
cells. Control luminal endothelium was characterized by intact basal lamina (BL) and inter-
endothelial junctions indicated by close contacts (Figure 5A). However, in diseased arteries 
endothelial integrity was severely compromised. The luminal endothelium appeared detached 
from the basal lamina (Figure 5B) with numerous intra-cytoplasmic vacuoles (Figure 5C). The 
inter-endothelial contact was incomplete or completely absent allowing infiltration of blood 
erythrocytes within the vessel wall (Figure 5C). In more advanced cases, the luminal 
endothelium showed signs of cellular death including lack of nucleus and denudated regions 
allowing exposure of the subendothelial space (Figure 5D). Similarly to the luminal endothelium, 
microvascular endothelium was also structurally compromised (Figures 5E-5H). In some cases, 
microvascular endothelial cells showed intact BL and closed inter-endothelial junctions (Figure 
5E). However in other cases, microvascular endothelial cells showed various structural changes 
(Figures 5F-5H). Although an intact basal lamina was generally observed, inter-endothelial 
contact was incomplete (Figure 5G; dashed allows) and endothelium morphology was 
changed to a more cuboidal-shape with numerous intra-cytoplasmic vacuoles (Figure 5G; 
arrows). Detachment of endothelial cells from the BL and leucocytes adhering to the 
microvessel lumen and infiltrating into the plaque were also observed (Figure 5H).  
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TEM and gadolinium mapping using x-ray spectra showed a diffuse distribution of 
gadofosveset across the vessel wall and lack of co-localization to particular plaque or vessel 
wall components (Figure 3; Supplemental Data). 
There were significant correlations between vascular permeability (measured by R1) and 
plaque area (measured by T1wBB) at 3 (r=0.23, P=0.03) and 12-weeks (r=0.24, P=0.03) (Figure 
4A and 4B; Supplemental Data). However, when the analysis was repeated with vascular 
segments classified as stable or rupture-prone the correlation was more significant for stable 
(r=0.4, P=0.004) but disappear for rupture-prone (r=0.2, P=0.44) lesions at 12-weeks (Figure 4C 
and 4D; Supplemental Data). We also found that the percentage increase in R1 was not 
followed by an equivalent increase in plaque area (Figure 5A; Supplemental Data). The 
percentage increase in vascular permeability (%ΔR1) to gadofosveset between 3 and 12-weeks 
was significantly higher for rupture-prone compared to stable plaque (50.80±7.2% vs. 
14.22±2.2%, P<0.001). However, the percentage increase of plaque area (%ΔT1wPA) was not 
statistically different between the two lesion types (35.00±3.5% vs. 41.00±9.0%, P=0.2). 
Furthermore, there was lack of correlation between the percentage change of plaque area (%Δ
T1wPA) and the percentage change in vascular permeability (%ΔR1) between 3 and 12-weeks 
(Figure 5B; Supplemental Data) when all lesions were included (r=0.16, P= 0.8). However, 
there was a significant correlation between %ΔT1wPA and %ΔR1 for stable (r=0.32, P=0.02), 
but not for rupture-prone lesions (r=-0.08, P=0.48) (Figure 5C and 5D; Supplemental Data).  
 
Intrinsic Vascular Elasticity Decreases in Diseased Vessels and is lower in Rupture-Prone 
compared to Stable Plaque   
Functional changes in the intrinsic vasodilation and wall stiffness were also investigated. The 
intrinsic vasodilation was lower in atherosclerotic compared to control animals 
(control=26.80±1.72% vs 3-weeks=23.43±0.8%, P=0.07, control vs 12-weeks =18.60±1.0%, 
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P<0.001) (Figure 6A). Vasodilation was even lower in rupture-prone compared to stable lesions 
at both the 3-weeks (21.21±1.3% vs. 24.41±1.13%, P=0.02) and 12-weeks time points 
(16.40±2.0% vs. 21.63±1.2%, P<0.001) (Figure 6B). However, there was lack of correlation 
between the intrinsic vasodilation and plaque area at both the 3 (r=-0.02, P=0.45) and 12-weeks 
(r=-0.02, P=0.5; data not shown).  
 Aortic stiffness measured with PWV increased in diseased aortas at 12-weeks compared 
to 3-weeks and control animals (5.00±0.1m/s, 2.50±0.2m/s, 2.53±0.2m/s) (Figure 6C). Paired t-
test showed a significant increase in PWV between 3- and 12-weeks in both animals with stable 
(2.49±0.3m/s vs. 5.23±0.4, P=0.03) and animals with rupture-prone (2.49±0.1m/s vs. 5.00±0.04, 
P<0.001) lesions. However, PWV was not statistically different between animals with stable and 
rupture-prone plaques at each time point (2.49±0.3m/s vs. 2.49±0.1m/s, P=1.0 and 
5.23±0.35m/s vs. 5.00±0.03m/s, P=0.55) (Figure 6D).  There was no correlation between PWV 
and plaque area at 3-weeks (r=0.54, P=0.2) but there was a significant correlation at 12-weeks 
(r=0.9, P=0.037) (Figure 6E) suggesting that lesion expansion increases arterial stiffening. 
Finally, there was a significant negative correlation between the percentage changes in the 
intrinsic vasodilation and arterial stiffness (r=-0.96, P=0.003) (Figure 6F). 
 
CONCLUSIONS 
This study demonstrates that vascular permeability, measured using an MR albumin-binding 
contrast agent and T1 mapping, is elevated in atherosclerotic compared to control vessels and, 
more importantly, is higher in rupture-prone compared to stable atherosclerotic lesions in a 
rabbit model of the disease. Increased vascular permeability measured in vivo was histologically 
validated by increased intra-vessel wall albumin, higher microvessel density and lack of 
structural integrity of both the luminal and microvascular endothelium. Functionally, the intrinsic 
capacity of the vessel wall to vasodilate was significantly lower in diseased, particularly, in 
rupture-prone lesions. Furthermore, pulse wave velocity analysis revealed significantly 
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increased arterial stiffness in atherosclerotic compared with control animals, but similar levels of 
stiffness between animals that had stable and rupture-prone lesions. We showed that MRI can 
quantify both morphological and functional changes of the vessel wall and that non-invasive 
quantification of vascular permeability using an albumin-binding MR contrast agent may have 
diagnostic value in detecting not only plaque progression but also unstable atherosclerotic 
lesions.  
Traditionally, “bright-blood” DCE-MRI has been used to study plaque permeability. 
Measurements demonstrated that the kinetic parameters including fractional plasma volume (vp) 
and Ktrans (expressing flow/permeability) correlate with microvessel density 21-24, adventitial vaso-
vasora 25, 26 and with sites of active inflammation 27. Ktrans was also used to monitor response to 
therapeutic intervention 38.  Human subjects treated with lipid lowering therapy for one year 
showed reduced Ktrans independently of a reduction in the lipid-rich necrotic core size or 
circulating levels of C-reactive protein 38.  Despite the promising applications of “bright blood” 
DCE-MRI, acquisitions are usually suited for the characterization of lesions thicker than 2mm, 
because of the close proximity of the enhancing vessel lumen, which makes vessel wall 
segmentation challenging. Alternatively, contrast uptake can be evaluated using “black-blood” 
DCE-MRI by measuring the area under the curve (AUC). Experiments in atherosclerotic rabbits 
showed a correlation between AUC, after administration of Gd-DTPA, and histological markers 
of plaque neovascularization 21.  
Our findings using a T1 mapping approach showed that the vessel wall relaxation rate 
(R1) after gadofosveset administration could also be used to quantify changes in vascular 
permeability in the context of atherosclerosis. We found that vessel wall permeability, measured 
as R1, was significantly higher at 12 compared to 3-weeks after commencing the experimental 
protocol and control animals. Importantly, rupture-prone plaques had significantly higher R1 
values and R1/ plaque area ratio compared to stable lesions at 12-weeks. The percent change in 
R1 between 3 and 12-weeks was also significantly higher for rupture-prone compared to stable 
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lesions. We have previously shown that vessel wall uptake of the albumin-binding contrast agent 
occurred through the progressive loss of luminal endothelial cell integrity in a murine model of 
atherosclerosis that lacked angiogenesis within the timeframe of the study 28. We also showed 
that treatments aiming to restore endothelial cell integrity decrease vascular permeability to 
albumin and retard plaque development 28, 29. Other studies have demonstrated that uptake of 
gadofosveset occurs through a combination of damaged endothelium and/or microvessels in 
experimental atherosclerosis 24, 28, 31.  In our current study, we found that leakage of the albumin-
binding contrast agent associates not only with plaque progression, as we have previously 
shown 28, 29, but also with lesion instability using a rabbit model that replicates multiple 
histological features described for human plaques 33, 36, 37. The ability to experimentally induce 
plaque rupture and thrombosis at a precise time point provides a functional end-point to 
retrospectively classify plaque as non-ruptured/ stable (no thrombus) or ruptured/vulnerable 
(mural thrombus). Therefore, this study protocol allows determination of imaging measurements 
that could potentially "predict" complication that cannot be achieved in the murine models we 
have previously used. The clinical utility of gadofosveset for vessel wall imaging was shown in a 
small proof-of-principle study that showed significantly higher gadofosveset uptake in 
symptomatic compared with asymptomatic human carotid plaques 23.  Our current results are in 
line with human data 23 and pinpoint the potential value of quantitative measurement of vascular 
permeability using the albumin-binding contrast agent for identification of high-risk/ unstable 
plaques.   
Histologically we found increased intra-vessel wall albumin 23, 24 and microvessel density 
in diseased, and in rupture plaques in particular. TEM analysis revealed loss of the endothelial 
integrity with disruption of inter-endothelial junctions in both the luminal and microvascular 
endothelium of atherosclerotic plaques. Both luminal and miscrovascular endothelial cells 
appeared detached from the basal lamina, had a cuboidal shape and numerous intra-
cytoplasmic vacuoles, a sign of increased secretory capacity. Inter-endothelial contact was 
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incomplete or absent allowing infiltration of blood cells (erythrocytes, leucocytes) into the vessel 
wall. Studies in humans showed that rupture-prone and ruptured coronary plaques exhibit a 2-
fold and 4-fold increase in microvessel density, respectively, compared to stable obstructive 
plaques 4, 15 Similarly, ruptured carotid endarterectomy 19, 20 and aortic 7 plaques had increased 
microvessel density, with larger,  immature, more irregular-shaped microvessels comparable to 
those found in tumors and healing wounds. Thin-walled microvessels showing incomplete 
endothelial junctions and lack of structural integrity have also been reported in human coronary 
plaques and were used to explain the extensive leukocyte infiltration, intraplaque hemorrhage, 
and plaque instability 11. Our histological data corroborate previous observations and suggest 
that increased microvessel density and compromised structural integrity (of both the luminal and 
microvascular endothelium) increase vascular leakage that facilitates extravasation of 
inflammatory cells and molecules that may contribute to plaque instability. Our in vivo 
measurements further validate ex vivo histological findings and provide a quantitative method for 
in situ measurement of focal vascular leakage associated with atherosclerosis progression and 
plaque instability using the albumin-binding contrast agent as a surrogate marker.  
Our study also revealed some in vivo mechanistic insights on the role of vascular 
leakage in the natural evolution of atherosclerosis and plaque instability. Although we found that 
vascular permeability was increased in diseased compared to control arteries and in rupture-
prone compared to stable lesions, the percentage increase in vascular permeability (%ΔR1) was 
not followed by an equivalent increase in plaque area (%ΔT1wPA) between 3 and 12-weeks 
when all arterial segments were analysed together. However, when stable and rupture-prone 
lesions were analysed independently, a significant correlation between %ΔT1wPA and %ΔR1 
was found for stable lesions. These data suggest that the rate of plaque growth maybe affected 
by changes in vascular permeability at earlier stages of disease progression. We speculate that 
at some point during plaque evolution increased vascular leakage because of i) increased 
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microvessel density, ii) differential permeability of individual microvessels, or iii) lack of structural 
integrity of the luminal or microvascular endothelium precedes plaque expansion causing a 
divergence from linearity between the increase of vascular permeability and focal lesion. To this 
end, measuring vascular permeability may provide a more sensitive biomarker for assessing 
atherosclerotic risk.  
This study has also revealed functional changes (vasodilation and stiffness) in the vessel 
wall in atherosclerosis, in particular in relation to the properties of stable compared with rupture- 
prone plaque. Intrinsic vasodilation decreased with the progression of atherosclerosis and was 
lower in rupture-prone compared with stable lesions. However, there was no significant 
correlation between the intrinsic vasodilation and plaque area suggesting that factors other than 
plaque size may contribute to the reduced vasodilation. Other studies have shown that structural 
changes in the vascular endothelium reduce endothelium-dependent vasodilation in response to 
endothelium stressors 9, 10 or mechanoreceptor signaling 39, 40. Endothelial cell (EC) surfaces 
have multiple mechanoreceptors that sense and respond to changes in endothelial shear stress 
(ESS) via intracellular mechanotransduction pathways. Physiologic pulsatile ESS regulates 
continuous nitric oxide (NO) production by the endothelium either at the transcriptional level, 
through upregulation of endothelial nitric oxide synthase (eNOS) gene expression 41, or at the 
post- transcriptional level by eNOS protein phosphorylation and activation 42. NO is a potent 
regulator of healthy vascular tone 43. Low ESS reduces the bioavailability of NO by decreasing 
eNOS messenger ribonucleic acid (mRNA) and protein expression, down-regulates prostacyclin, 
an endothelial vasodilatory substance 44 and upregulates endothelin-1 (ET-1) 44, a 
vasoconstrictive molecule. Although we did not measure ESS in this study, our previous work 
using this animal model demonstrated that low ESS was associated with plaque burden, positive 
vascular remodeling, and plaque instability 45. Similar results were shown using other animal 
models and in humans 46 and could probably explain the reduction in the intrinsic vasodilation. 
Our study also showed coupling between morphological (plaque area) and functional (stiffness) 
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vascular changes. PWV did not increase in the early stages of atherosclerosis (3-weeks), but 
increased after 12-weeks and correlated with plaque area. However, the increase in PWV was 
similar in animals with and without rupture-prone plaques. Our data suggest that vascular 
stiffening maybe a measure of overall vascular health (when atherosclerotic lesions are well 
formed), but it is not a surrogate marker of the propensity of a plaque to rupture in this animal 
model. Similar data have been reported in human studies where PWV was shown to increase 
with age 47, in the presence of calcification 48, hypertension 49  and intraplaque hemorrhage 50.  
 
STUDY LIMITATIONS 
A potential limitation of our study is that non-contrast T1wBB (0.31x0.31mm) had a higher in-
plane resolution compared with the T1 mapping (0.4x0.4mm) and that partial volume effects and 
motion might influence the accuracy of the R1 measurements. However, the thickness of the 
normal vessel wall in the rabbit aorta is ~0.5-0.6mm and therefore the in-plane resolution should 
have been sufficient to delineate the vessel wall on both sequences.  
The higher ICC observed for the intra-reader variability compared to the inter-reader 
variability is not surprising and suggested a higher variability between independent observers 
when manually segmenting the vessel wall for measuring the R1 when compared to the same 
observer. Manual vessel wall segmentation is known to be both time consuming and also 
subject to observer variability. In our study, the R1/T1 maps were analysed using a dedicated 
Matlab code that could only load the T1 mapping datasets. Fusion of the R1/T1 maps with the 
corresponding black-blood images that could potentially facilitate vessel wall segmentation was 
not possible. Future, adaptations of our code might allow for this function. In addition, the future 
use of 3D MOLLI- based T1 mapping sequences that allow for immediate reconstruction of the 
T1/R1 maps that can be directly imported on the DICOM viewer along with the black-blood 
images, perform image fusion and co-registration might also improve the accuracy and decrease 




Compromised structural integrity of the luminal and microvascular endothelium and higher 
microvessel density increase vascular permeability in atherosclerosis and particularly rupture-
prone plaque. T1 mapping using an albumin-binding contrast agent could be used to quantify 
changes of vascular permeability associated with atherosclerosis and plaque instability.  
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Table 1: Ability of MRI measurements in detecting rupture-prone plaques  
R1 ≥	1.9 s-1 and % 
(CI)




Sensitivity 81.2 (63.8-92.1) 90.6 (73.8-97.5) 65.6 (48.1-81.4)
Specificity 72.5 (58.0-83.6) 45.0 (91.8-59.5) 84.3 (71.4-92.9)
PPV 48.2 (37.2-59.3) 68.7 (57.4-78.2) 72.4 (52.8-87.3)




Figure 1: In vivo MRI shows higher vascular permeability in rupture-prone compared to 
stable plaque in rabbit atherosclerosis.  
Native pre-trigger T1wBB images acquired at 3 (A, C) and 12-weeks (E, G) show increased 
vessel wall thickening due to plaque formation. Corresponding R1 relaxation maps (B, D, F, H) 
shows higher vessel wall relaxation rate (R1)(orange/yellow color; arrows) in rupture-prone (H) 
compared with the stable plaque (F) at 12-weeks indicating higher vascular leakage to 
gadofosveset. Post-trigger T1wBB images (I, K) and histology (J, L) show the absence of 
thrombus at the site of a stable plaque and the presence of a thrombus overlying the ruptured 
plaque. Ao: aorta, V: vein. N=10 rabbits, 6 with ruptured and 4 without ruptured lesions were 
included in the MRI analyses.  
 
Figure 2: Quantification of MRI measurements after administration of gadofosveset.  
(A-B) Vessel wall R1 increased with disease progression and is higher in rupture-prone 
compared to stable plaque at 12-weeks. (C) R1/ plaque area was higher in rupture-prone 
compared to stable plaque at 12-weeks. (D) The percentage change in vessel wall R1 between 3 
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and 12-weeks was significantly higher in rupture-prone compared to stable plaque. N=10 
rabbits, 6 with ruptured and 4 without ruptured lesions were included in the MRI analyses    
 
Figure 3: Vascular permeability to gadofosveset is a predictor of plaque-prone plaques.  
Receiver-operator characteristic curve at 12-weeks showed that R1 (A), R1/ plaque area and (B), 
and the percentageΔR1 (C) from 3 to 12-weeks have high areas under the curve and are good 
predictors of plaque instability. N=10 rabbits, 6 with ruptured and 4 without ruptured lesions were 
included. 
 
Figure 4: Immunohistochemistry of rabbit atherosclerotic plaques.  
Albumin immunohistochemistry (A-C) and quantification of the albumin immunopositive area (D-
E) showed accumulation of albumin (brown color) in atherosclerotic vessel and particularly in 
ruptured compared to stable lesions. Endothelium immunohistochemistry staining (brown color) 
shows fragmented cells in ruptured (H) compared to stable plaque (G) and control tissue (F). 
Endothelium immunohistochemistry shows absence of microvessels in control tissue (I) and 
abundant microvessels (asterisks, *) in ruptured (K) compared to stable plaque (J). Microvessel 
density was higher in ruptured compared to stable plaque and absent in control vessels (L). 
P=plaque and M=media. N=18; 2 control, 10 stable and 6 ruptured plaques were included.   
 
Figure 5: Transmission electron microscopy of the structure of the endothelium.  
Images of luminal endothelial cells in control (A) and diseased aorta (B-D). The endothelium in 
control arteries had intact basal lamina and inter-endothelial junctions indicated by close contact. 
In diseased aortas, the endothelial integrity was compromised and the endothelium appeared 
detached from the basal lamina (B) with numerous intra-cytoplasmic vacuoles (C). The inter-
endothelial contact was incomplete or completely absent allowing infiltration of blood 
erythrocytes within the vessel wall (C). The luminal endothelium showed signs of overt cellular 
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death including lack of nucleus and denudated regions allowing exposure of the subendothelial 
space (D). Images of microvascular endothelial cells (E-H). Some microvascular endothelial 
cells showed intact basal lamina and closed inter-endothelial junctions (E). In other cases, 
although an intact basal lamina was observed (F), inter-endothelial contact was incomplete in 
plaque microvessels (G; dashed allows) and endothelial cell morphology was changed to a 
more cuboidal-shape with numerous intra-cytoplasmic vacuoles (G; arrows). Detachment of 
endothelial cells from the basal lamina, endothelial death and leucocytes adhering to the 
microvessel lumen thus infiltrating the plaque were also observed (H). BL: basal lamina, EC: 
endothelial cell, RBC: red blood cell. N=8; 2 control, 3 stable and 3 ruptured were included.  
 
Figure 6: Quantification of the Intrinsic Vasodilation and Arterial Stiffness in rabbits by 
MRI. The intrinsic vasodilation decreased in diseased compared to control aortas (A) and even 
more in rupture-prone compared to stable lesions (B). Pulse wave velocity indicative of vascular 
stiffness increases in diseased compared to control (C) animals but it is similar between animals 
with and without rupture-prone plaques (D). There was a significant correlation between plaque 
area and arterial stiffness at 12-weeks (E). There was a significant negative correlation between 
the percentage change of the intrinsic vasodilation and the pecentage change of the PWV 
between the 3 and 12-weeks (F). N=10 rabbits, 6 with ruptured and 4 without ruptured lesions 
were included. 
 
 
 
 
